Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir ODT Conversion in Stable Liver Transplant Patients
NCT07267208Phase 2Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of entecavir in hepatitis B (HBV). Planned start Dec 2026; status: not yet recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT07267208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07267208.